Drug intelligence / Profile preview

[18F]AlF-PSMA-11

Development stage
Preclinical
Lead developer
Telix Pharmaceuticals
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[18F]AlF-PSMA-11 is a radiopharmaceutical used in positron emission tomography (PET) imaging for the detection of prostate cancer lesions. It consists of a prostate-specific membrane antigen (PSMA) inhibitor labeled with fluorine-18 via an aluminum fluoride (AlF) chelation chemistry. The drug binds specifically to PSMA, a cell surface protein highly expressed in prostate cancer cells, allowing sensitive and specific imaging of primary tumors and metastatic disease. Compared to [68Ga]Ga-PSMA-11, [18F]AlF-PSMA-11 offers a longer half-life and potentially broader distribution[1][3][7]. It is primarily used for the diagnosis and staging of prostate cancer and evaluation of suspected recurrence[1][6][7][9].

Brand names
AlFluor
Other names
[18F]AlF-PSMA-1118F-AlF-PSMA-11
02

Targets

PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on [18F]AlF-PSMA-11.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [18F]AlF-PSMA-11.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call